Association of postpartum oxytocin dose and postpartum bleeding outcomes in nulliparous patients at term
Authors:
- 30 January 2025
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 233 (2) , 118.e1-118.e11
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Intravenous oxytocin dosing regimens for postpartum hemorrhage prevention following cesarean delivery: a systematic review and meta-analysisAmerican Journal of Obstetrics and Gynecology, 2021
- Guidelines for Active Management of the Third Stage of Labor using Oxytocin: AWHONN Practice Brief Number 12Nursing for Women's Health, 2021
- Quantitative Blood Loss in Obstetric HemorrhageObstetrics & Gynecology, 2019
- Effect of Immediate vs Delayed Pushing on Rates of Spontaneous Vaginal Delivery Among Nulliparous Women Receiving Neuraxial AnalgesiaJAMA, 2018
- Postpartum hemorrhage outcomes and raceAmerican Journal of Obstetrics and Gynecology, 2018
- Practice Bulletin No. 183 Summary: Postpartum HemorrhageObstetrics & Gynecology, 2017
- Global causes of maternal death: a WHO systematic analysisThe Lancet Global Health, 2014
- Dose and Duration of Oxytocin to Prevent Postpartum Hemorrhage: A ReviewAmerican Journal of Perinatology, 2012
- Midtrimester pregnancy termination: A randomized trial of prostaglandin E2 versus concentrated oxytocinAmerican Journal of Obstetrics and Gynecology, 1992
- Mid-Second-Trimester Labor Induction: Concentrated Oxytocin Compared With Prostaglandin E2 Vaginal SuppositoriesObstetrics & Gynecology, 1991